JPRN-jRCT1080224644已完成Unknown
Prospective, Post Marketing Surveillance of MOVICOL mixture
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 900
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 2age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with chronic constipation
排除标准
- 未提供
研究者
相似试验
已完成
Unknown
Prospective, Post Marketing Surveillance of GOOFICEChronic constipationJPRN-jRCT1080223950EA Pharma Co.,Ltd.3,000
进行中（未招募）
不适用
reactogenicity and safety of Vaxem™HibMeningitis, epiglottitis, pneumonia, arthritis caused by Haemophilus influenzae type b.EUCTR2014-005203-24-Outside-EU/EEAovartis Vaccines and Diagnostics750
招募中
4 期
A post marketing study to evaluate safety and effectiveness of Remogliflozin and Remogliflozin-Metformin Combination in treatment of Diabetes patientsCTRI/2019/11/022062Glenmark Pharmaceuticals Ltd
尚未招募
4 期
A post-marketing surveillance for the Evaluation of the safety of TGlobulin25 for the induction of immunosuppressive therapy in adult kidney transplant candidatesIRCT20201230049888N1Kawsar biotech company100
已完成
4 期
Phase IV Clinical Trial to Evaluate the Efficacy and Safety of basic Fibroblast Growth Factor Compared to Placebo in Combination with NBUVB for the Treatment of VitiligoIRCT20201104049265N1Imen Vaccine Alborz88